folder

The determinants of tumour immunogenicity

Authors

  • T. Blankenstein
  • P.G. Coulie
  • E. Gilboa
  • E.M. Jaffee

Journal

  • Nature Reviews Cancer

Citation

  • Nat Rev Cancer 12 (4): 307-313

Abstract

  • Many standard and targeted therapies, as well as radiotherapy, have been shown to induce an anti-tumour immune response, and immunotherapies rely on modulating the host immune system to induce an anti-tumour immune response. However, the immune response to such therapies is often reliant on the immunogenicity of a tumour. Tumour immunogenicity varies greatly between cancers of the same type in different individuals and between different types of cancer. So, what do we know about tumour immunogenicity and how might we therapeutically improve tumour immunogenicity? We asked four leading cancer immunologists around the world for their opinions on this important issue.


DOI

doi:10.1038/nrc3246